(Q33356272)

26 July 2017

title

Pemetrexed single agent chemotherapy in previously treated patients with locally advanced or metastatic non-small cell lung cancer (English)

1 reference

26 July 2017

1 reference

Alessandra Bearz

2

0 references

author name string

Francesca Russo

series ordinal

1

1 reference

26 July 2017

Gianni Pampaloni

series ordinal

3

1 reference

26 July 2017

Investigators of Italian Pemetrexed Monotherapy of NSCLC Group

series ordinal

4

1 reference

26 July 2017

language of work or name

English

0 references

publication date

31 July 2008

1 reference

26 July 2017

1 reference

26 July 2017

volume

8

1 reference

26 July 2017

page(s)

216

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2407-8-216

26 July 2017

exact match

0 references

cites work

Advances in chemotherapy of non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2529337

Review of the pemetrexed and gemcitabine combination in patients with advanced-stage non-small cell lung cancer

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2529337

Salvage therapy for advanced non-small cell lung cancer: factors influencing treatment selection

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2529337

Second-line treatment for advanced-stage non-small-cell lung cancer: current and future options.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2529337

Clinical activity of pemetrexed: a multitargeted antifolate anticancer agent

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2529337

Optimizing first-line treatment options for patients with advanced NSCLC.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2529337

Pemetrexed plus carboplatin or oxaliplatin in advanced non-small cell lung cancer

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2529337

Improving survival and reducing toxicity with chemotherapy in advanced non-small cell lung cancer : a realistic goal?

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2529337

Global cancer statistics, 2002

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2529337

Overview of phase I/II pemetrexed studies

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2529337

Pemetrexed: its promise in treating non-small-cell lung cancer.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2529337

Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2529337

A systematic overview of chemotherapy effects in non-small cell lung cancer

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2529337

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2529337

ALIMTA (pemetrexed disodium) as second-line treatment of non-small-cell lung cancer: a phase II study

14 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2407-8-216

Phase II Study of Pemetrexed With and Without Folic Acid and Vitamin B12 as Front-Line Therapy in Malignant Pleural Mesothelioma

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2407-8-216

Chemotherapy for advanced non-small-cell lung cancer

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18667090

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

LY231514, a pyrrolo[2,3-d]pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18667090

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2407-8-216

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference

26 July 2017

1 reference